Seelos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | BuyUS$99,999 | Raj Mehra | Individual | 591.85 | US$168.96 | |
30 Nov 23 | BuyUS$100,223 | Michael Golembiewski | Individual | 648.44 | US$154.56 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,135 | 0.49% |
Institutions | 19,620 | 4.5% |
General Public | 414,203 | 95% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1019.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,613 | US$6.7k | 55.3% | no data | |||
4,085 | US$4.9k | 492% | 0.03% | |||
3,365 | US$4.0k | -7.68% | no data | |||
2,194 | US$2.6k | 0% | no data | |||
1,446 | US$1.7k | 0% | no data | |||
1,391 | US$1.7k | 41.4% | no data | |||
1,333 | US$1.6k | 8.29% | no data | |||
799 | US$950.8 | -0.13% | no data | |||
679 | US$808.0 | 0% | no data | |||
435 | US$517.6 | -0.46% | no data | |||
241 | US$286.8 | 194% | no data | |||
62 | US$73.8 | 0% | no data | |||
31 | US$36.9 | 0% | no data | |||
29 | US$34.5 | 0% | no data | |||
13 | US$15.5 | -7.14% | no data | |||
9 | US$10.7 | 0% | no data | |||
7 | US$8.4 | 0% | no data | |||
7 | US$8.4 | 0% | no data | |||
3 | US$3.6 | -96.2% | no data | |||
2 | US$2.4 | 0% | no data | |||
1 | US$1.2 | 0% | no data | |||
1 | US$1.2 | 0% | no data | |||
1 | US$1.2 | 0% | no data | |||
1 | US$1.2 | 0% | no data | |||
1 | US$1.2 | 0% | no data |